Care of terminally-ill patients: an opinion survey among critical care healthcare providers in the Middle East.

Background: Modern medicine has allowed physicians to support the dying terminally-ill patient with artificial means. However, a common dilemma faced by physicians in general, and intensivist in particular is when to limit or withdraw aggressive intervention.

Objective: To study the effect of training background and seniority on Do-not to resuscitate (DNR) decisions in the Middle East.

Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shock.

Purpose: Changes of B-type natriuretic peptide (BNP) in sepsis and its utility in predicting intensive care unit outcomes remains a conflicting issue. To investigate the changes in plasma levels of BNP in patients with severe sepsis/septic shock and to study the association of BNP levels with the severity of the disease and prognosis of those patients.

Methods: Thirty patients with severe sepsis or septic shock were enrolled in our study.

Non-typhoidal Salmonella group D bacteremia and urosepsis in a patient diagnosed with HIV Infection.

Urinary tract infections caused by non-typhoid Salmonella are rare and usually develops in patients with predisposing factors such as immune deficiency or occult urologic problems. This report describes a case where Salmonella Group D was isolated from the blood and urine of a patient with documented human acquired immunodeficiency syndrome who developed urosepsis and was successfully treated with antibiotics.

Quinine-induced bronchiolitis obliterans and organizing pneumonia.

Quinine is a vital anti-malarial drug used in the management of resistant Falciparum malaria. There are previous reports of quinine-induced pulmonary edema and infiltrates. We report the first case of biopsy-proven bronchiolitis obliterans organizing pneumonia (BOOP), confirmed by the Naranjo Adverse Drug Reaction Probability Scale (NADRS) of 5 and a severity scale of 5, secondary to intravenous quinine, in a 15-year-old girl with Plasmodium falciparum infection after a visit to Kenya.

Evaluation of long-term infusion of dexmedetomidine in critically ill patients: A retrospective analysis.

Background: Dexmedetomidine is an α2-receptor agonist used for sedation in the intensive care unit (ICU). It is currently FDA indicated for short-term use (i.e.